Information for Authors
General
Information
The Journal
of the Korean Society for Research on Nicotine and Tobacco (J Korean Soc Res
Nicotine Tob, JKSRNT) is the official journal of the Korean Society for
Research on Nicotine and Tobacco. JKSRNT is an open access, peer-reviewed,
online-only journal published biannually (15th June and 15th December). Anyone
who would like to submit a manuscript is advised to carefully read the aims and
scope section of this journal. Manuscripts should be prepared for submission to
JKSRNT according to the following instructions.
Submission
and Peer Review Process
1. Submission
Authors
should submit their manuscripts online via the electronic submission system of
JKSRNT (www.jksrnt.org/review/Login.html). Once you have logged on to your
account, the online system will lead you through the submission process in a
step-by-step process. The submission instructions are available on the website.
All articles submitted to the journal must comply with these instructions.
Failure to do so will result in the return of the manuscript and possible delay
in publication.
2. Editorial
and Peer Review Process
A manuscript
is reviewed first for its format and suitability to the aims and scope of the
journal. If a manuscript clears these criteria, it is sent to the two most
relevant investigators in the field. The selection of the article will be based
on the review outcome. If there is a discrepancy concerning the review, the
selection will be decided pending further review by the Editorial Committee.
The editor will inform the author about the final decision on
acceptance/rejection for publication. All manuscripts are acknowledged on
receipt and receive editorial review within 2 weeks. The first decision time on
manuscripts sent for review is usually about 8 weeks. The revised manuscript
must be re-submitted within 8 weeks. The authors will be received the final
decision within 5-6 months after initial submission
Manuscript
Preparation
1. Categories
of Manuscripts
The published
types of articles are original articles, reviews, brief communications, case
reports, letters to the editor, and special invited contributions
2. Language
Manuscripts
should be written in English or Korean.
3. Reporting
Guidelines
Authors
should refer to the checklists detailed below for reporting of studies by type
of study design.
- CONSORT
(Consolidated Standards of Reporting Trials): http://www.consort-statement.org/
- STARD
(Standards for Reporting of Diagnostic Accuracy):
http://www.stard-statement.org/
- STROBE
(Strengthening the Reporting of Observational Studies in Epidemiology):
http://www.strobe-statement.org/
- PRISMA
(Preferred Reporting Items of Systematic Reviews and Meta-Analyses):
http://www.prisma-statement.org/
4.
Terminology
The generic
(non-proprietary) name for a drug is preferred in all instances. If it is
necessary to include the brand(proprietary or trade) name for reproduction or
interpretation of the study, the brand name should be given parenthetically,
following the generic name, at first mention in the abstract, text, and each
figure or table in which it appears. Additionally, the brand name and
supplierʼs name and location should be given in the ʻʻMethodsʼʼ section.
5.
Abbreviation Use
Abbreviations
can only be used after presentation (in parentheses) with the original full
name at first mention. Do not use abbreviations in the title or abstract and
limit their use in the text.
6. Nouns and
Units of Measurement
Human names,
place names, and proper nouns should be used as originally provided, and arabic
numerals should be employed for presentation of numbers. The metric system is
preferred for expression of length, area, mass, and volume data. Celsius is
preferred for temperature, and mmHg for blood pressure. Laboratory values
should be expressed using conventional units of measure or International Units
(SI).
7. General
Requirements
The main
document comprising the manuscript text and tables should be developed in
MSWord or RTF format.
Manuscripts
should be prepared in accordance with the Uniform Requirements for Manuscripts
Submitted to Biomedical Journals (http://www.icmje.org). All copies must be
prepared in 12-point font (Arial and Times New Roman preferred) and typed
double-spaced with 1-inch margins, on A4 pages numbered consecutively,
beginning with the title page.
8. Original
Article
1) Order of
sections
The
manuscript should be ordered in the following sequence: title of the study only
page (do not include authorsʼ names or affiliations; a second title page with
these details should be prepared separately, which will not be supplied to
reviewers), abstract and keywords, introduction, methods, results, discussion,
acknowledgments (optional), references, legends for figures, figures, and
tables. Each section should begin with a new page.
2) Length
Original
articles are generally limited to 4000 words with no more than 10 tables and
figures.
3) Title page
Authors
should separately prepare a page that includes important information. Titles
should not exceed 100 characters, including punctuation and spacing. Give full
names, highest academic degrees, orcid number, institutional affiliations and
position of all authors; if an authorʼs affiliation has changed since the work
was done, list the new affiliation as well. Designate a corresponding author
and include a complete mailing address, telephone number, fax number, and
e-mail address. Specify the address to which requests for reprints should be
sent. If the manuscript findings were presented at a meeting, please specify
its name, the city where it was held, and the exact date on which the paper was
read or the poster was presented. Also include on the title page a word count
for the text only, exclusive of the title, abstract, references, tables, and
figure legends. Conflict of interest: State any potential conflict of interest
that could influence the authorsʼ interpretation of the data, such as financial
support from or connections to companies, political pressure from interest
groups, or academically related issues.
If there are
more than two authors, their names should be listed sequentially, beginning
with the author who has made the greatest contribution to the article in the
descending order and each authorʼs name separated by a comma. If the authorʼs
affiliation is different, then separate it with a semicolon according to the
authorʼs order. If the affiliation is different from the first author, the
authors should be marked ʻʻ1,ʼʼ ʻʻ2,ʼʼ ʻʻ3,ʼʼ and so forth in Arabic numerals,
which should appear in superscript at the top-right-hand corner of the authorʼs
name and before the affiliation.
The author
responsible for correcting the handed-in article should be the corresponding
author and an asterisk (*) should appear in superscript at the top-right-hand
corner immediately following the authorʼs name. The corresponding author along
with the first author must assume responsibility for making corrections to the
handed-in paper during the review process. If the name of the corresponding
author is not disclosed, then the editorial committee assumes the first author
to be the corresponding author. The authorʼs name in English should be written
in the order ʻʻGiven name Surname.ʼʼ If the given name is separated by a space,
then capitalize the first letter of each given name. The title of the
manuscript should be succinct and should not be written as ʻʻResearch on…ʼʼ or
ʻʻDiscussions on….ʼʼ
4) Abstract
Include a
structured abstract of no more than 250 words for reports of original data from
clinical or basic science investigations and reviews (including meta-analyses).
Abstracts should consist of 4 paragraphs labeled Background, Methods, Results,
Conclusion (s). At the bottom of the abstract, authors should include keywords,
as listed in MeSH(Medical Subject Headings) of the National Library of Medicine
of the U.S (http://www.nlm.nih.gov/mesh/MBrowser.html).
5)
Introduction section
Describe the
background, principles, purpose, and importance of the study clearly. Do not
include results or conclusions.
6) Methods
section
Authors
should present the methods of the study precisely and describe them in detail
so that other people could perform the same study with the methods applied. The
name, city, and state or country of the source of equipment, tools, materials,
and reagents should be stated within parentheses.
Authors are
encouraged to consult ʻʻReporting Statistical Information in Medical Journal
Articles (http://archpedi.jamanetwork.com/article.aspx?articleid=481292).ʼʼ
Describe statistical methods with enough detail to enable a knowledgeable
reader with access to the original data to reproduce the reported results. When
possible, quantify findings and present them with appropriate indicators of
measurement error or uncertainty (such as confidence intervals). Avoid relying
solely on statistical hypothesis testing, such as the use of P values, which
fails to convey important quantitative information. Give details about
randomization. Describe the methods for and success of any blinding of
observations. Report complications of treatment. Give numbers of observations.
Report losses to observation (such as dropouts from clinical trials). For
multivariate models, report all variables included in the models. Include a
general description of methods in the ʻʻMethodsʼʼ section. Restrict tables and
figures to those needed to explain the argument of the article and to assess
its support. Use graphs as an alternative to tables with many entries; do not
duplicate data in figures and tables. Avoid nontechnical uses of technical
terms in statistics, such as random (which implies a randomizing device),
normal, significant, correlations, and sample. Define statistical terms,
abbreviations, and symbols. State the names of software packages for statistical
analysis.
7) Results
section
Describe the
results and findings from the study in a logical order with tables and figures.
Excessive repetition of the contents of tables or figures should be avoided;
summarize the data concisely.
8) Discussion
section
Discuss the
important or new findings from the results of the study and describe the
conclusions drawn. Do not repeat materials already presented in the background
or results sections. Describe the range of application of the study results,
limitations, and possibility of application in further research. Also, compare
the findings of the study with those of the previous related studies, and
connect the study aims with its conclusion. Avoid conclusions not based on the
data or allegations. Authors are encouraged to suggest new hypotheses from the
obtained data.
9)
Acknowledgment
List all
persons who have made substantial contributions to the work reported in the
manuscript (including writing and editing assistance), but who are not authors;
any financial interest in the subject matter or materials discussed in the
manuscript; any research or project support/funding; grant support. Manuscripts
with statistical evaluations should include the name and affiliation of
statistical reviewer(s). Authors should also obtain written permission to
include the names of individuals in the Acknowledgement section.
10)
References
The number of
references should be less than 30 for an original article. The ways to indicate
references in the text are as follows: (1) list references in consecutive
numerical order (in parentheses) at the end of the cited sentence; (2) use a
comma to separate multiple reference numbers; (3) and use ʻʻ-ʼʼ between the
first and last reference numbers in case of using 3 or more consecutive
reference numbers.
List all
authors and/or editors up to 6; if more than 6, list the first 6 and then ʻʻet
alʼʼ. Use the abbreviations of journal names used in the National Library of
Medicine (https://www.ncbi.nlm.nih.gov/sites/entrez?db=journals). References
accepted in a journal, but not yet published should be expressed as ʻʻin
pressʼʼ or ʻʻforthcomingʼʼ. For references under review in a journal, indicate
ʻʻunpublished observationʼʼ with ʻʻauthor namesʼʼ in parenthesis in the text
after obtaining permission from the author.
(1) Journal
articles
Author(s).
Title. Journal name year;volume:start page-last page.
- 6 or less
authors
Doll R, Peto
R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50
years observations
on British
doctors. Br J Cancer. 2005;92:426-9.
- 7 or more
authors
Kim DS, Kim
YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of Chronic Obstructive
Pulmonary
Disease in
Korea. Am J Respir Crit Care Med. 2005;172:842-7.
- Online
publication
Yu WM, Hawley
TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells.
Blood
2002;100:3828-31.
Epub 2002 Jul 5.
- In press
Leshner AI.
Molecular mechanisms of cocaine addiction. N Engl J Med. In press 2008.
(2) Books
Author(s).
Title (sub-title). Edition number. City of publication: Publisher name; year.
- Ringsven
MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY):
Delmar Publishers; 1996.
- Phillips
SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors.
Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York:
Raven Press; 1995. p. 465-78.
(3)
Dissertations
Author(s).
Title. City of university: University; Year. Language.
- Song YM.
The Relationship between low serum cholesterol level and cancer mortality
[dissertation]. Seoul: Seoul National Univ.; 1997. Korean.
- Kaplan SJ.
Post-hospital home health care: the elderly's access and utilization
[dissertation]. St. Louis (MO): Washington Univ.; 1995.
(4) News
papers
Author(s).
Title. Newspaper name. Issue date. Language.
- Jung SY.
Bimaneun mansungjilbyeong? Toechi campaign [Is obesity chronic disease?
Campaign to combat obesity]. Hankyoreh. 2002 Feb 27; Sect. 8. Korean.
- Tchernobyl,
20 ans apres: le vrai impact en France. Le Monde (France Metropolitan). 2006
Apr 25; Sect.1(col.5). French.
- Harris G.
FDA orders recall of intravenous pumps. New York Times (Washington Final). 2005
Jun 22; Sect. A:12 (col.1).
(5)
Electronic media
Internet-based
Journal Article (e-Journal)
- Kaul S,
Diamond GA. Good enough: a primer on the analysis and interpretation of
noninferiority trials. Ann Intern Med [Internet]. 2006; 145: 62-9 [cited 2008
Jan 4]. Available from: http://www.annals.org/cgi/reprint/145/1/62.pdf.
Internet-based
Book (e-Book)
- Higgins JP,
Green S, editors. Cochrane handbook for systematic reviews of interventions
[Internet]. Version 4.2.6. Chichester (UK): John Wiley & Sons, Ltd.; 2006
[updated 2006 Sep]. Chapter 3, Guide to the contents of a protocol and review;
[cited 2006 Nov 17]; p. 37-57. Available from:
http://www.cochrane.org/resources/handbook/handbook.pdf.
Webpages or
Homepages
- AMA:
helping doctors help patients [Internet]. Chicago: American Medical
Association; c1995-2007. [cited
2008 Feb 22].
Available from: http://www.ama-assn.org.
-
familydoctor.org [Internet]. Leawood (KS): American Academy of Family
Physicians; c2007 [cited 2008 Feb
20].
Available from: http://familydoctor.org.
- Fact sheet:
AIDS information resources [Internet]. Bethesda (MD): National Library of
Medicine (US); 2003.
May 2
[updated 2007 Feb 20; cited 2007 Mar 26]. Available from:
http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html.
11) Tables
In the order
of reference in the main text, provide a single space after the word ʻʻTableʼʼ
followed by an Arabic numeral that ends with a period. Do not use horizontal or
vertical lines within the table. Within a table, if an abbreviation is used or
description may be necessary, then list them under annotation below the table.
Use using the following symbols in this sequence: *, † , ‡ , §, ll, ¶ , **, ††
, etc to mark each footnote and ensure that each footnote in the table has a
corresponding note (and vice versa). List abbreviations in the footnote section
and explain any empty cells. For each annotation marked, capitalize the first
letter of the first word. E.g., capitalize the P of the P-value. The unit used
in a table should be marked within the table as far as possible precluding the
need to list outside of the table. The symbols for units should not be
capitalized. In making a table, the average, standard deviation, the number of
subjects, and others should be given and on the annotated part of the table,
the applied statistical method should be noted. For ratio, the number of
responders and the ratio, and for correlation coefficient, the value of
correlation coefficient should be given, respectively. In the main text, the
word table should be listed as ʻʻTable.ʼʼ
12) Figures
& legends for illustrations
Figures
should be numbered, using Arabic numerals, in the order in which they are
cited. Upload each figure as a single image file in either uncompressed jpg or
gif format over 600 dpi (dots per inch) or 3 million pixel (less than 6
megabytes). Written permission should be obtained for the use of all previously
published illustrations (and copies of permission letters should be included).
When illustrating a figure, use a bar or a line graph for average or
proportion, and list measures using standard deviation or standard error and
show their P-values. Identify the applied statistical methods at the footnote
of each figure. In the case of multiple prints bearing the same number, use
English letters after the numerals to indicate the correct order; for example,
Fig. 1A, Fig. 2B, C.
9. Reviews
Reviews should
be a comprehensive analysis of specific topics, which are organized as follows:
main text (title page, abstract and keywords, introduction, text, conclusion,
conflict of interest, acknowledgments (if necessary), and references), tables,
and figures. There should be an unstructured abstract equal to or less than 350
words. There is no word limit for reviews.
10. Case
Reports
Manuscript
should be ordered in the following sequence: title page, abstract and keywords,
background, case, discussion, acknowledgments (optional), references, legends
of figures and tables, figures, and tables. Each section should begin with a
new page. Case-reports should be focused on unexpected or hitherto unreported
findings.
11. Other
Types of Manuscript (brief communications, letters to the editor, special
invited contributions etc.)
Brief
communications are short research articles intended to present exciting
findings that will have a major impact in the JKSRNT. A brief communication
manuscript should be prepared in the order of sequence as an original article.
Maximums: structured abstract, 150 words; word counts of the text, 1,500 words;
number of references, 20; number of figures and tables, 2. For a letter to the
editor, an abstract is not required, and a brief text should be prepared with
references. The maximum word count of the text is 1,000. Special invited
contributions should be a comprehensive analysis of specific topics, which are
invited by editorial committee and organized as follows: title page, abstract
and keywords, introduction, main body of text, conclusions, acknowledgments
(optional), references, legends of figures and tables, figures, and tables.
Final
Preparation for Publication
1. Manuscript
Revision
After the
paper has been accepted for publication, the author(s) should submit the final
version of the manuscript. Before publication, the manuscript editor will
correct the manuscript such that it meets the standard publication formats so
long as it does not alter the general idea of the article. The author must
respond within two (2) days when the manuscript editor contacts the author for
revisions. If the response is delayed, the publication of the manuscript may be
postponed to the next issue.
2. Decisions
on Publication
All
manuscripts that do not follow the guidelines of the JKSRNT will be recommended
for revision. A decision on publication of the manuscript will be made by the
editorial committee after the review process.
3. Galley
Proof
The author
will receive the final version of the manuscript as a PDF file. Upon receipt,
within two (2) days, the editorial office (or printing office) must be notified
of any errors found in the file. Any errors found after this time are the
responsibility of the author and will have to be corrected as an erratum.
4. Copyright
/Licensing information
The copyright
of the manuscript accepted for publication is transferred to the JKSRNT.
Authors should sign the copyright transfer form and upload it on the submission
site or send it by e-mail to journal@ksrnt.org. Copyrights of all published
materials are owned by the Korean Society for Research on Nicotine and Tobacco.
The Korean Society for Research on Nicotine and Tobacco also follows the
Creative Commons Attribution Non-commercial License as an open-access journal.
*These
instructions for authors are effective as of April 1st, 2019.